Ask HopeStage to review this study with me
Study ID: NCT06271954. We help you review the study, but cannot decide medical eligibility.
UnknownNCT06271954
The Relationship Between Emotion Regulation and Psychiatric Disorder in Youth
This study has public registry information. It focuses on depression and currently lists study information in Taiwan.
Depression, ADHD, ...OtherFrom 15 Years to 24 Years
Key information made simple
This observational study is following people with depression, anxiety, Attention Deficit Hyperactivity Disorder, or Adjustment Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
Your next step
The official record suggests a mix of remote and in-person participation through a hospital, with sites including Chang-Geng Medical Foundation Chang-Geng Memorial Hospital in Keelung. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually matching the main diagnosis and meeting the main study requirements, while common reasons not to take part include other factors that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: March 27, 2023
- Recruitment status
- Unknown
- Estimated enrollment
- Not clearly listed
- Sponsor
- Chang Gung Memorial Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Taiwan
- Age range
- From 15 Years to 24 Years
- Official registry ID
- NCT06271954
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT06271954. We help you review the study, but cannot decide medical eligibility.
Key study information
- Condition
- Depression, ADHD, ...
- Study status
- Unknown
- Sponsor / lead affiliation
- Chang Gung Memorial Hospital
- Location / country
- Taiwan
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06271954
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help improve understanding of your condition.
It requires regular visits and structured follow-up.
Mixes in-person and remote participation.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring observational follow-up for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Is this an interview, survey, or observational study?
This appears to be a interview / survey / observational study. Phase is mainly useful to check for medication studies and some device studies.
Who might this study be for?
This study may concern people with depression; age range: From 15 Years to 24 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to answer questionnaires or take part in interviews. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could the questions feel emotionally difficult or personal?
If the study involves interviews or questionnaires, some questions may feel personal or emotionally sensitive. Ask whether you can skip questions, pause, stop, and how your answers will be protected. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Chang Gung Memorial Hospital, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The recruitment status is not clearly listed. Check the official registry or contact the study team.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meOther studies you may want to explore next
TerminatedNCT05518149
Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)
This study has public registry information in the United States, in Australia, in France, .... It is testing aticaprant for depression.
RecruitingNCT07412756
Brenipatide in adults with Major Depressive Disorder
This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.
RecruitingNCT07227454
Esketamine for depression
This study is recruiting in the United States, in Brazil, and in Taiwan. It is testing esketamine for depression.